BIRC5 and hepatocellular carcinoma: Meta-analysis showed that BIRC5, FEN1 and EGFR could be the key targets of Aidi injection against hepatocellular carcinoma, and the three chemical components exerted synergistic inhibitory effects through their targets, respectively, which revealed the mechanism of anti-hepatocellular carcinoma of Aidi injection, and also provided a typical example for the pharmacological evaluation of other proprietary Chinese medicines.